Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohort - Wikidata - wikimedia - TriplyDB

Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohort

Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohort

http://www.wikidata.org/entity/Q29417147

about

Alzheimer's therapeutics: translation of preclinical science to clinical drug development The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception Genetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkers Neurological imaging: statistics behind the pictures Insights into the genetic architecture of early stage age-related macular degeneration: a genome-wide association study meta-analysis.GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.Genomic variants, genes, and pathways of Alzheimer's disease: An overview.Epigenetic signature and enhancer activity of the human APOE gene.A human carboxypeptidase E/NF-α1 gene mutation in an Alzheimer's disease patient leads to dementia and depression in mice.2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.Alzheimer's disease risk genes and the age-at-onset phenotype.Low plasma leptin in cognitively impaired ADNI subjects: gender differences and diagnostic and therapeutic potential.Genome-wide network-based pathway analysis of CSF t-tau/Aβ1-42 ratio in the ADNI cohort.Association analysis of rare variants near the APOE region with CSF and neuroimaging biomarkers of Alzheimer's disease.The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.Genetic modification of the relationship between phosphorylated tau and neurodegeneration.Alzheimer's and ABC transporters--new opportunities for diagnostics and treatment.Genome-wide association study of CSF levels of 59 alzheimer's disease candidate proteins: significant associations with proteins involved in amyloid processing and inflammation SUCLG2 identified as both a determinator of CSF Aβ1-42 levels and an attenuator of cognitive decline in Alzheimer's disease.Association between NME8 locus polymorphism and cognitive decline, cerebrospinal fluid and neuroimaging biomarkers in Alzheimer's disease.Genetic loci associated with Alzheimer's disease and cerebrospinal fluid biomarkers in a Finnish case-control cohort.Prevalence of Alzheimer's pathologic endophenotypes in asymptomatic and mildly impaired first-degree relatives.Function and comorbidities of apolipoprotein e in Alzheimer's disease.TOMM40 rs2075650 polymorphism shows no association with neovascular age-related macular degeneration or polypoidal choroidal vasculopathy in a Chinese population.The Broad Impact of TOM40 on Neurodegenerative Diseases in Aging Using CSF biomarkers to replicate genetic associations in Alzheimer's disease.Evaluation of the global association between cholesterol-associated polymorphisms and Alzheimer's disease suggests a role for rs3846662 and HMGCR splicing in disease risk.The "Alzheimer's disease signature": potential perspectives for novel biomarkers.Comprehensive gene- and pathway-based analysis of depressive symptoms in older adults.A genome-wide association meta-analysis of plasma Aβ peptides concentrations in the elderly.Amyloid pathway-based candidate gene analysis of [(11)C]PiB-PET in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort.Functional analysis of APOE locus genetic variation implicates regional enhancers in the regulation of both TOMM40 and APOE.Variations in the FRA10AC1 Fragile Site and 15q21 Are Associated with Cerebrospinal Fluid Aβ1-42 Level.Genome-wide association study identifies multiple novel loci associated with disease progression in subjects with mild cognitive impairment.Promising Genetic Biomarkers of Preclinical Alzheimer's Disease: The Influence of APOE and TOMM40 on Brain Integrity.ABC Transporters and the Alzheimer's Disease Enigma.Candidate genes for Alzheimer's disease are associated with individual differences in plasma levels of beta amyloid peptides in adults with Down syndrome.Integration of bioinformatics and imaging informatics for identifying rare PSEN1 variants in Alzheimer's disease.HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group Epistasis analysis links immune cascades and cerebral amyloidosis.

P2860

352bcba4de7e072e14d663d013b8e351f0535fba

P248

Q26829267-12D303B1-7BCA-4FAC-9C2B-76F09736AA3D Q27006831-E0738CC3-3C75-4FFD-B017-62502ABCFF12 Q28542010-BB855C47-F2A9-4E94-B256-F89676DCB9C9 Q28741434-BEED3F5B-8C1C-4CBD-8ADB-73A09756F2F1 Q29417048-F3BE10BC-8E15-4738-99B0-91CAD75418E1 Q29417137-68EA3590-EC83-4A4A-A13A-FBD731DBDBC2 Q30240093-9897E943-BA5D-41CF-A7DA-747DCF8D2D68 Q30557542-51A557A9-5E33-4B98-A1AE-5D3F2709CF4B Q30839130-E4FE7208-2E69-48E5-B363-8275E304873D Q30971403-91D498A2-7744-4A87-A839-508F7051DD44 Q33685232-82A3AD4E-A91B-4363-89C5-F1345AA539C2 Q33692408-CB498990-3752-4A07-88A0-583DC8749078 Q33743209-DA0BC9E0-9DE6-43B8-A38F-8A8C163C4E15 Q33770976-1E3CC86D-4074-4EAC-8BB2-A9F46DFF1516 Q34065449-7F5473F0-E930-4220-806D-3F64CA44FAA0 Q34216985-D197D087-DCEE-42F2-BA30-63AF5CEA622A Q34353553-A5BEC5EB-418A-4EB6-AEED-50E6F3376738 Q34394932-29474E49-81FB-4D5E-A390-5694ED565717 Q34429207-98A365AD-2D68-4A55-8A11-5E53C262851C Q34654986-DABE023F-2A67-4BF5-872C-41F35A7D16DF Q34661700-35463DA3-1DC7-4AE3-A0BD-BE2507598688 Q34683758-A18F3996-F96E-4B21-B5F5-DE05E63F0E7E Q34951817-64738339-FBD6-4740-9333-BFBEE69E3AE8 Q35022261-BF0811CF-E5E9-4971-860A-7BD7CDDFF58B Q35137172-5A2A3335-B361-43C5-8FC8-C74AD3D76E4D Q35148534-3C4AFA09-6437-4CFA-8316-0B9D55F50861 Q35232774-2D474B6A-CAD0-44EB-8C2A-79AC8702E4D6 Q35339326-1AA2D0F4-92D9-4CFC-9D65-AE6B70AEA71B Q35434690-7C9BCBD1-5D3F-4D72-B59A-D6B389A339DB Q35565629-DC728CD1-2B2F-46AD-B2DE-781CF0CC1142 Q35667139-BF9395A3-DA05-4697-AACE-0BCE7C384C41 Q35696751-C651AA0D-8EB7-403B-B3B9-6271780B9DAA Q35740031-03744E11-072D-4FC6-BB59-5EAAA43A3C6E Q35844054-601C54FA-1D60-45B4-8DB7-C8FDF9305E9F Q35895780-33A75FC2-C5C4-4830-A21C-FD125ADE7A38 Q36005085-313CA85E-71AA-4ACF-98C7-A87C708B26C9 Q36037548-2FD0E4F3-478D-4734-8B49-60FABD468108 Q36106356-425A6D67-7438-4610-83ED-AEA5F1BE61A4 Q36147395-AF717BED-56EF-41AA-A5A0-4C6D43D6D171 Q36337137-7B818F31-B84E-4B79-8C0C-1C63125BBD2F

P2860

Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohort

http://www.wikidata.org/entity/Q29417147

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Genome-wide association study ...... d p-tau181p in the ADNI cohort

@ast

Genome-wide association study ...... d p-tau181p in the ADNI cohort

@en

type

label

Genome-wide association study ...... d p-tau181p in the ADNI cohort

@ast

Genome-wide association study ...... d p-tau181p in the ADNI cohort

@en

prefLabel

Genome-wide association study ...... d p-tau181p in the ADNI cohort

@ast

Genome-wide association study ...... d p-tau181p in the ADNI cohort

@en

P1433

Q29417147-FDD1FA62-3EF7-4ED6-AE2E-444B4CBBA1C9

P1476

Q29417147-44A808C4-F98C-403F-A634-E84284E31BD4

P2093

Q29417147-1E684486-72BE-4CB2-AE93-26924B30EE0C

Q29417147-1FB1F026-7F93-4534-A88F-8037537F4DAE

Q29417147-25F35278-1C64-405B-AD6A-9889172A308F

Q29417147-3FF1B7E5-576F-4AB4-978A-5F7EF9469A49

Q29417147-5BA02254-4172-41A9-B76D-BCFA22C75067

Q29417147-64211AA3-C99D-437A-AB22-B8B1F4179E87

Q29417147-6B22F16A-74DC-4D8C-8B3C-6BBFCDE4FF81

Q29417147-6FCE0D5F-ED0A-4DB6-882B-24D6C2E59F39

Q29417147-781032B9-FC02-4C96-ADBE-F2AFAE58A0C3

Q29417147-853BCA10-1138-475B-8610-90696C80BFEF

P2860

Q29417147-01B4AC3D-CDE9-4569-96DF-27243734ECCA

Q29417147-084EC91D-F23F-4225-A7CF-FA8FB0853E63

Q29417147-10B76360-17A3-4353-9B50-F9BA1DCACD2D

Q29417147-12E8137E-E697-4914-85CC-59BF3A3AADA3

Q29417147-2A28C906-A1E5-4583-808A-43A58F82D620

Q29417147-2F6ED275-C625-48A8-ADE0-9BA77629550A

Q29417147-3087441C-B557-4EC8-91FA-3EE829398DEC

Q29417147-35851699-775D-4BAF-9503-1C50EB233C24

Q29417147-3C76729E-5E22-4090-BE27-A63A209AEA8C

Q29417147-3D4A90F2-9EBF-4101-BA91-95721815DFD7

P304

Q29417147-EAFAFDC5-B15B-43D4-AB54-DEA037FD45DC

P31

Q29417147-3C0A0D22-2A6E-45EA-B6E8-3E40E6509378

P3181

Q29417147-EDF64BA6-DD8E-47F0-837F-26BC2CA69884

P356

Q29417147-139ADA27-E2BE-442F-B224-E4DE68A0C005

P407

Q29417147-5971C7FB-2CBE-476F-BE10-BF14F3FBFCB8

P433

Q29417147-943A7845-27CA-4D32-A779-07B0499F74A3

P478

Q29417147-5B42A436-0837-45A6-A42C-64EDB5552FA1

P50

Q29417147-CDE2F291-38B2-474B-965F-DF33160D38BB

Q29417147-CFBE2644-B2D4-4A23-B122-20F80BFE8FBD

P577

Q29417147-51E02CC1-E0F9-4E69-8597-837815FF07DC

P5875

Q29417147-6A7528FF-8677-4858-B24B-074D9C869BF9

P698

Q29417147-8DFF9487-53A5-4BC1-9838-B34A1AF5786F

P921

Q29417147-4757331E-2021-4BF7-8A53-545657292843

Q29417147-5BF23181-7F3F-464B-A4B4-30B63E738FCA

P932

Q29417147-BED3D4C7-363E-4B9A-96B2-2D10642DE220

P3181

P356

WNL.0B013E318204A397

P1433

P1476

Genome-wide association study ...... d p-tau181p in the ADNI cohort

@en

P2093

A J Saykin

http://www.w3.org/2001/XMLSchema#string

B M DeChairo

http://www.w3.org/2001/XMLSchema#string

D W Craig

http://www.w3.org/2001/XMLSchema#string

J Q Trojanowski

http://www.w3.org/2001/XMLSchema#string

K Nho

http://www.w3.org/2001/XMLSchema#string

L M Shaw

http://www.w3.org/2001/XMLSchema#string

M J Huentelman

http://www.w3.org/2001/XMLSchema#string

M W Weiner

http://www.w3.org/2001/XMLSchema#string

P S Aisen

http://www.w3.org/2001/XMLSchema#string

R C Petersen

http://www.w3.org/2001/XMLSchema#string

P2860

Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer's disease

Role of Genes and Environments for Explaining Alzheimer Disease

Structural and functional conservation of the NuA4 histone acetyltransferase complex from yeast to humans

Genome-wide association studies in Alzheimer's disease

PLINK: a tool set for whole-genome association and population-based linkage analyses

Comprehensive analysis of APOE and selected proximate markers for late-onset Alzheimer's disease: patterns of linkage disequilibrium and disease/marker association.

The structure of haplotype blocks in the human genome

Haploview: analysis and visualization of LD and haplotype maps

Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium

Brain-derived neurotrophic factor activation of NFAT (nuclear factor of activated T-cells)-dependent transcription: a role for the transcription factor NFATc4 in neurotrophin-mediated gene expression

P304

69-79

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4096971

http://www.w3.org/2001/XMLSchema#string

P356

10.1212/WNL.0B013E318204A397

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

76

http://www.w3.org/2001/XMLSchema#string

P50

Alzheimer's Disease Neuroimaging Initiative

P577

2010-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49650926

http://www.w3.org/2001/XMLSchema#string

P698

21123754

http://www.w3.org/2001/XMLSchema#string

P921

genome-wide association study

P932

3030225

http://www.w3.org/2001/XMLSchema#string